Molecular oncology testing in resource-limited settings

Journal of Molecular Diagnostics

Volumn 16, Issue 6, 2014, Pages 601-611

  Gulley, Margaret L ^a   Morgan, Douglas R ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; BIOMOLECULAR ELECTRONICS; BIOSENSOR; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COMPUTER PROGRAM; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DEVICE MAINTENANCE; DIAGNOSTIC TEST; DNA HYBRIDIZATION; ELECTROCHEMICAL DETECTION; ELECTRON TRANSPORT; ELECTRONIC SENSOR; EPSTEIN BARR VIRUS; FOLLOW UP; GENE REARRANGEMENT; GENETIC VARIABILITY; HEALTH CARE COST; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYBRIDIZATION; INFECTION; LAB ON A CHIP; LABORATORY DEVICE; LIVER CELL CARCINOMA; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; LUNG CANCER; LYMPHOMA; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; MOBILE PHONE; MOLECULAR ELECTRONICS; NANOTECHNOLOGY; OPPORTUNISTIC INFECTION; OROPHARYNX CARCINOMA; PATIENT EDUCATION; POLYMERASE CHAIN REACTION; PORTABLE EQUIPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RURAL AREA; STAFF TRAINING; STOMACH ADENOCARCINOMA; TELEMEDICINE; TELEPATHOLOGY; THERMOCYCLER; TUBERCULOSIS; TUMOR BIOPSY; TURNAROUND TIME; UTERINE CERVIX CANCER; VIRUS PATHOGENESIS; WART VIRUS; COMMUNICABLE DISEASE; COMPLICATION; DEVELOPING COUNTRY; GENETICS; HEALTH CARE ORGANIZATION; NEOPLASMS;

COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; HEALTH CARE RATIONING; HUMANS; NEOPLASMS;

EID: 84908099183     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.07.002     Document Type: Review

References (109)

1. C.D. Chin, V. Linder, and S.K. Sia Commercialization of microfluidic point-of-care diagnostic devices Lab Chip 12 2012 2118 2134
2. L. Jennings, V.M. Van Deerlin, and M.L. Gulley Recommended principles and practices for validating clinical molecular pathology tests Arch Pathol Lab Med 133 2009 743 755
3. C. de Martel, J. Ferlay, S. Franceschi, J. Vignat, F. Bray, D. Forman, and M. Plummer Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
4. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study Lancet 349 1997 1498 1504
5. P.E. Goss, B.L. Lee, T. Badovinac-Crnjevic, K. Strasser-Weippl, Y. Chavarri-Guerra, and J. St Louis Planning cancer control in Latin America and the Caribbean Lancet Oncol 14 2013 391 436
6. P. Farmer, J. Frenk, F.M. Knaul, L.N. Shulman, G. Alleyne, L. Armstrong, R. Atun, D. Blayney, L. Chen, R. Feachem, M. Gospodarowicz, J. Gralow, S. Gupta, A. Langer, J. Lob-Levyt, C. Neal, A. Mbewu, D. Mired, P. Piot, K.S. Reddy, J.D. Sachs, M. Sarhan, and J.R. Seffrin Expansion of cancer care and control in countries of low and middle income: a call to action Lancet 376 2010 1186 1193
7. I. Magrath, E. Steliarova-Foucher, S. Epelman, R.C. Ribeiro, M. Harif, C.K. Li, R. Kebudi, S.D. Macfarlane, and S.C. Howard Paediatric cancer in low-income and middle-income countries Lancet Oncol 14 2013 e104 e116
8. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, S.A. Aparicio, S. Behjati, and A.V. Biankin Signatures of mutational processes in human cancer Nature 500 2013 415 421
9. M.L. Gulley, and W. Tang Laboratory assays for Epstein-Barr virus-related disease J Mol Diagn 10 2008 279 292
10. G. Quiroga-Garza, H. Zhou, D.R. Mody, M.R. Schwartz, and Y. Ge Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype? Arch Pathol Lab Med 137 2013 1569 1573
11. D. Ramogola-Masire, C.M. McGrath, K.T. Barnhart, H.M. Friedman, and N.M. Zetola Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana Int J Gynecol Pathol 30 2011 591 596
12. A. Gulliksen, H. Keegan, C. Martin, J. O'Leary, L.A. Solli, I.M. Falang, P. Gronn, A. Karlgard, M.M. Mielnik, I.R. Johansen, T.R. Tofteberg, T. Baier, R. Gransee, K. Drese, T. Hansen-Hagge, L. Riegger, P. Koltay, R. Zengerle, F. Karlsen, D. Ausen, and L. Furuberg Towards a "sample-in, answer-out" point-of-care platform for nucleic acid extraction and amplification: using an HPV E6/E7 mRNA model system J Oncol 2012 2012 905024
13. G. Spizz, L. Young, R. Yasmin, Z. Chen, T. Lee, D. Mahoney, X. Zhang, G. Mouchka, B. Thomas, W. Honey, T. Roswech, C. McGuire, R. Montagna, and P. Zhou Rheonix CARD((R)) Technology: an innovative and fully automated molecular diagnostic device Point Care 11 2012 42 51
14. F.H. Zhao, J. Jeronimo, Y.L. Qiao, J. Schweizer, W. Chen, M. Valdez, P. Lu, X. Zhang, L.N. Kang, P. Bansil, P. Paul, C. Mahoney, M. Berard-Bergery, P. Bai, R. Peck, J. Li, F. Chen, M.H. Stoler, and P.E. Castle An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China Cancer Prev Res (Phila) 6 2013 938 948
15. H. Ying, F. Jing, Z. Fanghui, Q. Youlin, and H. Yali High-risk HPV nucleic acid detection kit-the careHPV test -a new detection method for screening Sci Rep 4 2014 4704
16. L.A. Trope, B. Chumworathayi, and P.D. Blumenthal Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand J Low Genit Tract Dis 17 2013 315 319
17. S. Untiet, P. Vassilakos, C. McCarey, P.M. Tebeu, G. Kengne-Fosso, P.A. Menoud, M. Boulvain, I. Navarria, and P. Petignat HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy Int J Cancer 135 2014 1911 1917
18. V.M. Verhoef, R.P. Bosgraaf, F.J. van Kemenade, L. Rozendaal, D.A. Heideman, A.T. Hesselink, R.L. Bekkers, R.D. Steenbergen, L.F. Massuger, W.J. Melchers, J. Bulten, L.I. Overbeek, J. Berkhof, P.J. Snijders, and C.J. Meijer Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial Lancet Oncol 15 2014 315 322
19. Y. Guan, P.E. Gravitt, R. Howard, Y.J. Eby, S. Wang, B. Li, C. Feng, Y.L. Qiao, and P.E. Castle Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens J Virol Methods 189 2013 167 171
20. T.Y. Odesanmi, S.P. Wasti, O.S. Odesanmi, O. Adegbola, O.O. Oguntuase, and S. Mahmood Comparative effectiveness and acceptability of home-based and clinic-based sampling methods for sexually transmissible infections screening in females aged 14-50 years: a systematic review and meta-analysis Sex Health 10 2013 559 569
21. C. Nordfors, A. Vlastos, J. Du, A. Ahrlund-Richter, N. Tertipis, N. Grun, M. Romanitan, L. Haeggblom, A. Roosaar, G. Dahllof, M.G. Dona, M. Benevolo, T. Ramqvist, E. Munck-Wikland, and T. Dalianis Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer Oral Oncol 50 2014 491 497
22. J. Zabaleta Multifactorial etiology of gastric cancer Methods Mol Biol 863 2012 411 435
23. C. He, H. Tu, L. Sun, Q. Xu, P. Li, Y. Gong, N. Dong, and Y. Yuan Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese Carcinogenesis 34 2013 1450 1457
24. T. Essawi, W. Hammoudeh, I. Sabri, W. Sweidan, and M.A. Farraj Determination of Helicobacter pylori virulence genes in gastric biopsies by PCR ISRN Gastroenterol 2013 2013 606258
25. C. Ek, M.T. Whary, M. Ihrig, L.E. Bravo, P. Correa, and J.G. Fox Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians Helicobacter 17 2012 107 115
26. I.B. Tan, I. Ng, W.M. Tai, and P. Tan Understanding the genetic basis of gastric cancer: recent advances Expert Rev Gastroenterol Hepatol 6 2012 335 341
27. W. Tang, D.R. Morgan, M.O. Meyers, R.L. Dominguez, E. Martinez, K. Kakudo, P.F. Kuan, N. Banet, H. Muallem, K. Woodward, O. Speck, and M.L. Gulley Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile Infect Agent Cancer 7 2012 21
28. A. Morgner, R. Schmelz, C. Thiede, M. Stolte, and S. Miehlke Therapy of gastric mucosa associated lymphoid tissue lymphoma World J Gastroenterol 13 2007 3554 3566
29. B.H. Schmitt, M. Regner, K.A. Mangold, R.B. Thomson Jr., and K.L. Kaul PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies Mod Pathol 26 2013 1222 1227
30. V. Singh, S. Mishra, G.R. Rao, A.K. Jain, V.K. Dixit, A.K. Gulati, D. Mahajan, M. McClelland, and G. Nath Evaluation of nested PCR in detection of Helicobacter pylori targeting a highly conserved gene: HSP60 Helicobacter 13 2008 30 34
31. T.T. Perkins, C.Y. Tay, F. Thirriot, and B. Marshall Choosing a benchtop sequencing machine to characterise Helicobacter pylori genomes PLoS One 8 2013 e67539
32. T. Falsafi, R. Favaedi, F. Mahjoub, and M. Najafi Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children World J Gastroenterol 15 2009 484 488
33. R.N. Arboleda, B.G. Schneider, L.E. Bravo, J. Romero-Gallo, R.M. Peek Jr., R.M. Mera, M.C. Yepez, C. Campo, and P. Correa Use of the noninvasive entero-test in the detection of Helicobacter pylori in children in an endemic area in Colombia J Pediatr Gastroenterol Nutr 57 2013 192 196
34. N. Nishida, and M. Kudo Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma Oncology 84 Suppl 1 2013 93 97
35. G.R. Han, C.L. Xu, W. Zhao, and Y.F. Yang Management of chronic hepatitis B in pregnancy World J Gastroenterol 18 2012 4517 4521
36. R.L. Morgan, B. Baack, B.D. Smith, A. Yartel, M. Pitasi, and Y. Falck-Ytter Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies Ann Intern Med 158 2013 329 337
37. M. Cabezas-Fernandez, and M. Cabeza-Barrera Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses Open Virol J 6 2012 122 134
38. S. Chevaliez, C. Rodriguez, and J.M. Pawlotsky New virologic tools for management of chronic hepatitis B and C Gastroenterology 142 2012 1303 1313.e1
39. Q. Wang, H. Wang, X. Yang, K. Wang, F. Liu, Q. Zhao, P. Liu, and R. Liu Multiplex detection of nucleic acids using a low cost microfluidic chip and a personal glucose meter at the point-of-care Chem Commun (Camb) 50 2014 3824 3826
40. M.R. Petrara, L. Elefanti, M. Quaggio, M. Zanchetta, M.C. Scaini, N. Masalu, A. De Rossi, and C. Menin Dried blood spot sampling for detection of monoclonal immunoglobulin gene rearrangement Leuk Res 37 2013 1265 1270
41. I.J. Snijdewind, J.J. van Kampen, P.L. Fraaij, M.E. van der Ende, A.D. Osterhaus, and R.A. Gruters Current and future applications of dried blood spots in viral disease management Antiviral Res 93 2012 309 321
42. W. Tang, P. Harmon, M.L. Gulley, C. Mwansambo, P.N. Kazembe, F. Martinson, C. Wokocha, S.C. Kenney, I. Hoffman, C. Sigel, S. Maygarden, M. Hoffman, and C. Shores Viral response to chemotherapy in endemic burkitt lymphoma Clin Cancer Res 16 2010 2055 2064
43. M.R. Petrara, M. Penazzato, W. Massavon, S. Nabachwa, M. Nannyonga, A. Mazza, K. Gianesin, P. Del Bianco, R. Lundin, C. Sumpter, M. Zanchetta, C. Giaquinto, and A. De Rossi Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda J Infect Dis 210 2014 392 399
44. M. Mancuso, L. Jiang, E. Cesarman, and D. Erickson Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles Nanoscale 5 2013 1678 1686
45. L. Jiang, M. Mancuso, Z. Lu, G. Akar, E. Cesarman, and D. Erickson Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics Sci Rep 4 2014 4137
46. Y.H. Yu, C.C. Liao, W.H. Hsu, H.J. Chen, W.C. Liao, C.H. Muo, F.C. Sung, and C.Y. Chen Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study J Thorac Oncol 6 2011 32 37
47. K. Dheda, M. Ruhwald, G. Theron, J. Peter, and W.C. Yam Point-of-care diagnosis of tuberculosis: past, present and future Respirology 18 2013 217 232
48. L.E. Scott, K. McCarthy, N. Gous, M. Nduna, A. Van Rie, I. Sanne, W.F. Venter, A. Duse, and W. Stevens Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study PLoS Med 8 2011 e1001061
49. D.W. Dowdy, J.L. Davis, S. den Boon, N.D. Walter, A. Katamba, and A. Cattamanchi Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa PLoS One 8 2013 e70485
50. Centers for Disease Control and Prevention (CDC) Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use: United States, 2013 MMWR Morb Mortal Wkly Rep 62 2013 821 827
51. A. Van Rie, L. Page-Shipp, C.F. Hanrahan, K. Schnippel, H. Dansey, J. Bassett, K. Clouse, L. Scott, W. Stevens, and I. Sanne Point-of-care Xpert(R) MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa Int J Tuberc Lung Dis 17 2013 368 372
52. J. Cutrell, and R. Bedimo Non-AIDS-defining cancers among HIV-infected patients Curr HIV/AIDS Rep 10 2013 207 216
53. D.H. Mulama, J.A. Bailey, J. Foley, K. Chelimo, C. Ouma, W.G. Jura, J. Otieno, J. Vulule, and A.M. Moormann Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer Int J Cancer 134 2014 645 653
54. B.O. Ondondo Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers Front Immunol 5 2014 90
55. P. Aka, M.C. Vila, A. Jariwala, F. Nkrumah, B. Emmanuel, M. Yagi, N.M. Palacpac, M.V. Periago, J. Neequaye, C. Kiruthu, T. Tougan, P.H. Levine, R.J. Biggar, R.M. Pfeiffer, K. Bhatia, T. Horii, J.M. Bethony, and S.M. Mbulaiteye Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response Blood 122 2013 629 635
56. L. Xu, and J. Kong A multiplexed nucleic acid microsystem for point-of-care detection of HIV co-infection with MTB and PCP Talanta 117 2013 532 535
57. J.H. Wang, L. Cheng, C.H. Wang, W.S. Ling, S.W. Wang, and G.B. Lee An integrated chip capable of performing sample pretreatment and nucleic acid amplification for HIV-1 detection Biosens Bioelectron 41 2013 484 491
58. M.K. Haleyur Giri Setty, and I.K. Hewlett Point of Care Technologies for HIV AIDS Res Treat 2014 2014 497046
59. Y. Li, N. Kumar, A. Gopalakrishnan, C. Ginocchio, R. Manji, M. Bythrow, B. Lemieux, and H. Kong Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation J Mol Diagn 15 2013 634 641
60. M. Imwong, S. Hanchana, B. Malleret, L. Rénia, N.P. Day, A. Dondorp, F. Nosten, G. Snounou, and N.J. White High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias J Clin Microbiol 52 2014 3303 3309
61. D.A. Goff, C. Jankowski, and F.C. Tenover Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs Pharmacotherapy 32 2012 677 687
62. C.A. Petti, C.R. Polage, T.C. Quinn, A.R. Ronald, and M.A. Sande Laboratory medicine in Africa: a barrier to effective health care Clin Infect Dis 42 2006 377 382
63. J.D. Khoury, N.M. Tannir, M.D. Williams, Y. Chen, H. Yao, J. Zhang, E.J. Thompson, F. Meric-Bernstam, L.J. Medeiros, J.N. Weinstein, and X. Su Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq J Virol 87 2013 8916 8926
64. L. Yan, J. Zhou, Y. Zheng, A.S. Gamson, B.T. Roembke, S. Nakayama, and H.O. Sintim Isothermal amplified detection of DNA and RNA Mol Biosyst 10 2014 970 1003
65. S. Kitano, J. Myers, J. Nakamura, A. Yamane, M. Yamashita, M. Nakayama, Y. Tsukahara, H. Ushida, W. Liu, M.J. Ratain, and M. Amano A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection PLoS One 8 2013 e62989
66. J.D. Roberts, G.A. Wells, M.R. Le May, M. Labinaz, C. Glover, M. Froeschl, A. Dick, J.F. Marquis, E. O'Brien, S. Goncalves, I. Druce, A. Stewart, M.H. Gollob, and D.Y. So Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial Lancet 379 2012 1705 1711
67. K.D. Bernacki, B.L. Betz, H.C. Weigelin, C.D. Lao, B.G. Redman, S.M. Knoepp, and M.H. Roh Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study Am J Clin Pathol 138 2012 670 677
68. B. McCall, R.J. Olsen, N.J. Nelles, D.L. Williams, K. Jackson, R. Richards-Kortum, E.A. Graviss, and T.S. Tkaczyk Evaluation of a miniature microscope objective designed for fluorescence array microscopy detection of Mycobacterium tuberculosis Arch Pathol Lab Med 138 2014 379 389
69. N. Mosammaparast, A.J. McAdam, and F.S. Nolte Molecular testing for infectious diseases should be done in the clinical microbiology laboratory J Clin Microbiol 50 2012 1836 1840
70. D.T. Geraets, R. van Baars, I. Alonso, J. Ordi, A. Torne, W.J. Melchers, C.J. Meijer, and W.G. Quint Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge J Clin Virol 57 2013 125 129
71. B.L. Quincy, D.J. Turbow, and L.N. Dabinett Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer J Obstet Gynaecol 32 2012 87 91
72. R.H. Ng, R. Ngan, W.I. Wei, P.J. Gullane, and J. Phillips Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma Otolaryngol Head Neck Surg 150 2014 602 609
73. J. Shan, E.H. Pow, P.C. Tsang, R.A. Perera, and D.L. Kwong Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients J Investig Clin Dent 5 2014 104 108
74. N.E. Brown-Connolly, J.B. Concha, and J. English Mobile health is worth it! Economic benefit and impact on health of a population-based mobile screening program in New Mexico Telemed J E Health 20 2014 18 23
75. D.R. Seiner, H.A. Colburn, C. Baird, R.A. Bartholomew, T. Straub, K. Victry, J.R. Hutchison, N. Valentine, and C.J. Bruckner-Lea Evaluation of the FilmArray(R) system for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis J Appl Microbiol 114 2013 992 1000
76. A.A. Fatah, R. Arcilesi, J. Peterson, C.H. Lattin, C.Y. Wells, and J.A. McClintock Guide for the Selection of Chemical Detection Equipment for Emergency First Responders Guide 100-06, DHS Guide 100-06 3rd ed. 2007 National Institute of Standards and Technology Gaithersburg, MD
77. C.D. Chin, Y.K. Cheung, T. Laksanasopin, M.M. Modena, S.Y. Chin, A.A. Sridhara, D. Steinmiller, V. Linder, J. Mushingantahe, G. Umviligihozo, E. Karita, L. Mwambarangwe, S.L. Braunstein, J. van de Wijgert, R. Sahabo, J.E. Justman, W. El-Sadr, and S.K. Sia Mobile device for disease diagnosis and data tracking in resource-limited settings Clin Chem 59 2013 629 640
78. S. Zhang, Y. Lin, J. Wang, P. Wang, J. Chen, M. Xue, S. He, W. Zhou, F. Xu, P. Liu, P. Chen, S. Ge, and N. Xia A convenient nucleic acid test on the basis of the capillary convective PCR for the on-site detection of enterovirus 71 J Mol Diagn 16 2014 452 458
79. K. Morabito, R. Kantor, W. Tai, L. Schreier, and A. Tripathi Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART) J Mol Diagn 15 2013 401 412
80. P. Craw, and W. Balachandran Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review Lab Chip 12 2012 2469 2486
81. L.E. Perez, G.A. Merrill, R.A. DeLorenzo, T.W. Schoenfeld, A. Vats, and M.J. Moser Evaluation of the specificity and sensitivity of a potential rapid influenza screening system Diagn Microbiol Infect Dis 75 2013 77 80
82. F.B. Myers, R.H. Henrikson, J. Bone, and L.P. Lee A handheld point-of-care genomic diagnostic system PLoS One 8 2013 e70266
83. Q. Zhu, Y. Gao, B. Yu, H. Ren, L. Qiu, S. Han, W. Jin, Q. Jin, and Y. Mu Self-priming compartmentalization digital LAMP for point-of-care Lab Chip 12 2012 4755 4763
84. B. Smolarz, T. Krawczyk, B. Westfal, R. Maciejczyk, M. Zadrozny, D. Samulak, M.M. Michalska, E. Mojs, M. Wilczak, and H. Romanowicz-Makowska Comparison of one-step nucleic acid amplification (OSNA) method and routine histological investigation for intraoperative detection of lymph node metastasis in Polish women with breast cancer Pol J Pathol 64 2013 104 108
85. Y. Muto, H. Matubara, T. Tanizawa, Y. Nabeya, H. Kawahira, T. Akai, I. Hoshino, and H. Hayashi Rapid diagnosis of micrometastasis of gastric cancer using reverse transcription loop-mediated isothermal amplification Oncol Rep 26 2011 789 794
86. W. Tang, Z. Hu, H. Muallem, and M.L. Gulley Quality assurance of RNA expression profiling in clinical laboratories J Mol Diagn 14 2012 1 11
87. B. Lam, J. Das, R.D. Holmes, L. Live, A. Sage, E.H. Sargent, and S.O. Kelley Solution-based circuits enable rapid and multiplexed pathogen detection Nat Commun 4 2013 2001
88. M. Guarnaccia, G. Gentile, E. Alessi, C. Schneider, S. Petralia, and S. Cavallaro Is this the real time for genomics? Genomics 103 2014 177 182
89. A.S. Patterson, K. Hsieh, H.T. Soh, and K.W. Plaxco Electrochemical real-time nucleic acid amplification: towards point-of-care quantification of pathogens Trends Biotechnol 31 2013 704 712
90. V. Yapo, Td d'Aquin Toni, S. Desmonde, C. Amani-Bosse, M. Oga, S. Lenaud, H. Menan, M. Timité-Konan, V. Leroy, and C. Rouzioux Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire: the Pedi-Test DBS ANRS 12183 Study J Virol Methods 193 2013 439 445
91. S. Mohamed, A. Raimondo, G. Penaranda, C. Camus, D. Ouzan, S. Ravet, M. Bourliere, H. Khiri, P. Dukan, D. Olive, and P. Halfon Dried blood spot sampling for hepatitis B virus serology and molecular testing PLoS One 8 2013 e61077
92. L.C. Ivers, M.C. Smith Fawzi, J. Mann, J.G. Jerome, M. Raymonville, and J.S. Mukherjee Overseas processing of dried blood spots for timely diagnosis of HIV in Haitian infants Rev Panam Salud Publica 24 2008 331 335
93. P.W. Smit, K.A. Sollis, S. Fiscus, N. Ford, M. Vitoria, S. Essajee, D. Barnett, B. Cheng, S.M. Crowe, T. Denny, A. Landay, W. Stevens, V. Habiyambere, J.H. Perriens, and R.W. Peeling Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis PLoS One 9 2014 e86461
94. S.M. Berry, A.J. LaVanway, H.M. Pezzi, D.J. Guckenberger, M.A. Anderson, J.M. Loeb, and D.J. Beebe HIV viral RNA extraction in wax immiscible filtration assisted by surface tension (IFAST) devices J Mol Diagn 16 2014 297 304
95. S.M. Hewitt, S.S. Badve, and L.D. True Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy Clin Cancer Res 18 2012 1524 1530
96. C. Mathay, W. Yan, R. Chuaqui, A.P. Skubitz, J.P. Jeon, N. Fall, F. Betsou, and M. Barnes Short-term stability study of RNA at room temperature Biopreserv Biobank 10 2012 532 542
97. S.E. Howlett, H.S. Castillo, L.J. Gioeni, J.M. Robertson, and J. Donfack Evaluation of DNAstable for DNA storage at ambient temperature Forensic Sci Int Genet 8 2014 170 178
98. Commission on Office Laboratory Accreditation (COLA): Federal Government Questions Quality in Waived Testing. The Hard Facts and What Can Laboratories Do Now? A COLA White Paper. Available online at http://www.colainsider.com/cola-issues-waived-testing-white-paper-calls-for-more-education-at-waived-testing-sites (last updated April 22, 2013)
99. H. Hoenecke, V. Lee, and I. Roy Pathologists overseas: coordinating volunteer pathology services for 19 years Arch Pathol Lab Med 135 2011 173 178
100. P.T. Cagle Pathologists as leaders, innovators, and devoted physicians: special section on pathology in resource-poor nations Arch Pathol Lab Med 135 2011 170
101. H.I. Harder Pathology services in developing countries Arch Pathol Lab Med 133 2009 1911
102. J.W. Carlson, E. Lyon, D. Walton, W.C. Foo, A.C. Sievers, L.N. Shulman, P. Farmer, V. Nose, and D.A. Milner Jr. Partners in pathology: a collaborative model to bring pathology to resource poor settings Am J Surg Pathol 34 2010 118 123
103. F.M. Knaul, L.N. Shulman, J. Gralow, J. Quick, A. Bhadelia, and J. Frenk Improving pathology for better cancer care and control in countries of low and middle income Lancet 379 2012 2052
104. D.J. Roberts, M.L. Wilson, A.M. Nelson, A.M. Adesina, K.A. Fleming, D. Milner, J. Guarner, T.R. Rebbeck, P. Castle, and S. Lucas The good news about cancer in developing countries-pathology answers the call Lancet 379 2012 712
105. Rebbeck TR: Handbook for Cancer Research in Africa. African Organisation for Research and Training in Cancer. Brazzaville, Republic of Congo, World Health Organization, 2013
106. B. Tetu, and A. Evans Canadian licensure for the use of digital pathology for routine diagnoses: one more step toward a new era of pathology practice without borders Arch Pathol Lab Med 138 2014 302 304
107. S. Gopal, R. Krysiak, N.G. Liomba, M.J. Horner, C.G. Shores, N. Alide, S. Kamiza, C. Kampani, F. Chimzimu, Y. Fedoriw, D.P. Dittmer, M.C. Hosseinipour, and I.F. Hoffman Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses PLoS One 8 2013 e70361
108. D. Gallegos, K.D. Long, H. Yu, P.P. Clark, Y. Lin, S. George, P. Nath, and B.T. Cunningham Label-free biodetection using a smartphone Lab Chip 13 2013 2124 2132
109. X. Liu, T.Y. Lin, and P.B. Lillehoj Smartphones for cell and biomolecular detection Ann Biomed Eng 2014 [Epub ahead of print] doi: 10.1007/s10439-014-1055-z